Matthew Chau Hsien Ng

6PUBLICATIONS
92CO-AUTHORS
Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 07, 2026
Spatial organisation of tumor-infiltrating B-cells informs immune checkpoint inhibitor response in Claudin 18.2-expressing gastric cancer.

|Nov 09, 2024
Real-World Outcomes for Localised Gastro-Oesophageal Adenocarcinoma Cancer Treated with Perioperative FLOT and Prophylactic GCSF Support in a Single Asian Centre.

Wanyi Kee, Kennedy Yao Yi Ng, Shun Zi Liong

|May 21, 2024
Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial.

Petros Grivas, Elena Garralda, Funda Meric-Bernstam

|Feb 09, 2021
"3G" Trial: An RNA Editing Signature to Guide Gastric Cancer Chemotherapy.

Omer An, Yangyang Song, Xinyu Ke

|Jan 27, 2021
Overcoming the impact of the COVID-19 pandemic on oncology early phase trials and drug development in Asia-Experiences and perspectives of the Asian Oncology Early Phase 1 Consortium.

Toshio Shimizu, Dong-Wan Kim, Herbert H Loong

|Nov 19, 2019
What is the value of third-line chemotherapy in advanced gastroesophageal cancer? A 5-year retrospective analysis at a single center.

Justina Yick Ching Lam, Su Pin Choo, David Wai-Meng Tai

Pageof 1

Frequent Collaborators

2 joint publications

Sun Young Rha

2 joint publications

Raghav Sundar

2 joint publications

Jimmy Bok-Yan So

1 joint publications

María Rodríguez Martínez